Ikena Oncology, Inc.IKNANASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
+27.2%/yr
Quarterly compound
Percentile
P88
Within normal range
vs 3Y Ago
2.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 45.55% |
| Q3 2025 | -826.09% |
| Q2 2025 | 67.90% |
| Q1 2025 | 5.53% |
| Q4 2024 | 10.85% |
| Q3 2024 | 25.46% |
| Q2 2024 | 14.96% |
| Q1 2024 | 17.15% |
| Q4 2023 | -12.37% |
| Q3 2023 | -1.33% |
| Q2 2023 | -20.37% |
| Q1 2023 | -8.71% |
| Q4 2022 | 22.14% |
| Q3 2022 | 16.13% |
| Q2 2022 | -19.83% |
| Q1 2022 | -697.64% |
| Q4 2021 | 119.27% |
| Q3 2021 | -14.46% |
| Q2 2021 | -30.52% |
| Q1 2021 | 62.70% |
| Q4 2020 | -318.69% |
| Q3 2020 | -23.50% |
| Q2 2020 | 27.46% |
| Q1 2020 | -35.96% |
| Q4 2019 | 0.00% |